Is IDEXX Laboratories a good investment? Analyzing its consistent growth, innovative products, and international expansion ...

Truist Financial Corp grew its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 13.9% in the 4th ...

IDEXX Laboratories (NASDAQ:IDXX – Free Report) had its price objective upped by Piper Sandler from $435.00 to $510.00 in a research report report published on Monday morning,Benzinga reports. Piper ...

IDEXX Laboratories, Inc.’s IDXX fourth-quarter performance was driven by the consistent strong performance of the Companion Animal Group (“CAG”) segment. Solid performance in the international markets ...

Baron Funds, an investment management company, released its “Baron Asset Fund” fourth quarter 2024 investor letter. A copy of ...

If an investor was to purchase shares of IDXX stock at the current price level of $433.50/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock ...

Piper Sandler analyst David Westenberg maintained a Hold rating on Idexx Laboratories (IDXX – Research Report) today and set a price target of ...

Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the ...

In the fourth quarter of 2024, CAG Diagnostics’ recurring revenues are likely to have been supported by improvements in average global net prices and international organic gains. IDEXX ...